Scotland · NHS Scotland MSAN
Pancrease® HL gastro-resistant capsules
MSAN(2023)34 · Level 2 · issued 16 Oct 2023
What the notice states
The supply position for each affected product, as recorded in the notice — read the full signed PDF above for the clinical advice and actions.
| Product | Position | Resupply |
|---|---|---|
| Valid until: discontinuation, stock to be exhausted by mid-November 2023 | Discontinued | — |
| 1. Pancrease® HL gastro-resistant capsules are being discontinued with stock expected to be | Discontinued | — |
| 2. Alternative high strength pancreatin preparations remain available and will be able to support | Available | — |
| Registration for access to the website is available to UK healthcare professionals and | Available | — |
From the NHS Scotland notice PDF (linked above); dates and “valid until” text are as stated, fuzzy wording kept as written. Scotland is covered separately from England — see methodology. Not an official NHS service, and not clinical advice — follow the guidance issued to your pharmacy.